AAAAAA

   
Results: 1-14 |
Results: 14
Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up
Authors: Kashyap, R Jain, A Reyes, J Demetris, AJ Elmagd, KA Dodson, SF Marsh, W Madariaga, V Mazariegos, G Geller, D Bonham, CA Cacciarelli, T Fontes, P Starzl, TE Fung, JJ
Citation: R. Kashyap et al., Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up, TRANSPLAN P, 33(1-2), 2001, pp. 1482-1483
Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up
Authors: Kashyap, R Jain, A Reyes, J Demetris, AJ Elmagd, KA Dodson, SF Marsh, W Madariaga, V Mazariegos, G Geller, D Bonham, CA Cacciarelli, T Fontes, P Starzl, TE Fung, JJ
Citation: R. Kashyap et al., Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up, TRANSPLAN P, 33(1-2), 2001, pp. 1486-1487
Liver-derived DEC205(+)B220(+)CD19(-) dendritic cells regulate T cell responses
Authors: Lu, LN Bonham, CA Liang, XY Chen, ZY Li, W Wang, LF Watkins, SC Nalesnik, MA Schlissel, MS Demestris, AJ Fung, JJ Qian, SG
Citation: Ln. Lu et al., Liver-derived DEC205(+)B220(+)CD19(-) dendritic cells regulate T cell responses, J IMMUNOL, 166(12), 2001, pp. 7042-7052
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation
Authors: Dodson, SF de Vera, ME Bonham, CA Geller, DA Rakela, J Fung, JJ
Citation: Sf. Dodson et al., Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation, LIVER TRANS, 6(4), 2000, pp. 434-439
Prolongation of cardiac allograft survival using dendritic cells treated with NF kappa B decoy oligodeoxyribonucleotides (vol 1, pg 430, 2000)
Authors: Giannoukakis, N Bonham, CA Qian, SG Chen, ZY Peng, LS Harnaha, J Li, W Thomson, AW Fung, JJ Robbins, PD Lu, L
Citation: N. Giannoukakis et al., Prolongation of cardiac allograft survival using dendritic cells treated with NF kappa B decoy oligodeoxyribonucleotides (vol 1, pg 430, 2000), MOL THER, 2(3), 2000, pp. 298-298
Prolongation of cardiac allograft survival using dendritic cells treated with NF-kappa B decoy oligodeoxyribonucleotides
Authors: Giannoukakis, N Bonham, CA Qian, SG Zhou, ZY Peng, L Harnaha, J Li, W Thomson, AW Fung, JJ Robbins, PD Lu, L
Citation: N. Giannoukakis et al., Prolongation of cardiac allograft survival using dendritic cells treated with NF-kappa B decoy oligodeoxyribonucleotides, MOL THER, 1(5), 2000, pp. 430-437
Is the pathologic TNM staging system for patients with hepatoma predictiveof outcome?
Authors: Marsh, JW Dvorchik, I Bonham, CA Iwatsuki, S
Citation: Jw. Marsh et al., Is the pathologic TNM staging system for patients with hepatoma predictiveof outcome?, CANCER, 88(3), 2000, pp. 538-543
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center
Authors: Jain, A Reyes, J Kashyap, R Dodson, F Demetris, AJ Ruppert, K Abu-Elmagd, K Marsh, W Madariaga, J Mazariegos, G Geller, D Bonham, CA Gayowski, T Cacciarelli, T Fontes, P Starzl, TE Fung, JJ
Citation: A. Jain et al., Long-term survival after liver transplantation in 4,000 consecutive patients at a single center, ANN SURG, 232(4), 2000, pp. 490-498
Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes theirin vitro tolerogenicity and survival in allogeneic recipients
Authors: Lu, L Gambotto, A Lee, WC Qian, S Bonham, CA Robbins, PD Thomson, AW
Citation: L. Lu et al., Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes theirin vitro tolerogenicity and survival in allogeneic recipients, GENE THER, 6(4), 1999, pp. 554-563
Excision and immediate revascularization for hepatic artery pseudoaneurysmfollowing liver transplantation
Authors: Bonham, CA Kapur, S Geller, D Fung, JJ Pinna, A
Citation: Ca. Bonham et al., Excision and immediate revascularization for hepatic artery pseudoaneurysmfollowing liver transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 443-443
Potential use of marginal donors for pancreas transplantation
Authors: Bonham, CA Kapur, S Dodson, SF Dvorchik, I Corry, RJ
Citation: Ca. Bonham et al., Potential use of marginal donors for pancreas transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 612-613
Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors
Authors: Dodson, SF Bonham, CA Geller, DA Cacciarelli, TV Rakela, J Fung, JJ
Citation: Sf. Dodson et al., Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors, TRANSPLANT, 68(7), 1999, pp. 1058-1061
Strategies to expand the donor pool for pancreas transplantation
Authors: Kapur, S Bonham, CA Dodson, SF Dvorchik, I Corry, RJ
Citation: S. Kapur et al., Strategies to expand the donor pool for pancreas transplantation, TRANSPLANT, 67(2), 1999, pp. 284-290
Central nervous system lesions in liver transplant recipients - Prospective assessment of indications for biopsy and implications for management
Authors: Bonham, CA Dominguez, EA Fukui, MB Paterson, DL Pankey, GA Wagener, MM Fung, JJ Singh, N
Citation: Ca. Bonham et al., Central nervous system lesions in liver transplant recipients - Prospective assessment of indications for biopsy and implications for management, TRANSPLANT, 66(12), 1998, pp. 1596-1604
Risultati: 1-14 |